Equifax, Inc. $EFX Shares Sold by Ethic Inc.

Ethic Inc. cut its holdings in Equifax, Inc. (NYSE:EFX) by 4.1% in the 2nd quarter, HoldingsChannel reports. The fund owned 5,387 shares of the credit services provider’s stock after selling 231 shares during the period. Ethic Inc.’s holdings in Equifax were worth $1,380,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in Equifax by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 14,708,331 shares of the credit services provider’s stock valued at $3,582,361,000 after acquiring an additional 318,826 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Equifax by 40.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 7,037,804 shares of the credit services provider’s stock valued at $1,714,129,000 after acquiring an additional 2,009,987 shares during the last quarter. Harris Associates L P increased its holdings in shares of Equifax by 27.6% during the 1st quarter. Harris Associates L P now owns 4,570,557 shares of the credit services provider’s stock worth $1,113,205,000 after buying an additional 987,772 shares during the last quarter. Generation Investment Management LLP increased its holdings in shares of Equifax by 63.4% during the 1st quarter. Generation Investment Management LLP now owns 2,801,325 shares of the credit services provider’s stock worth $682,291,000 after buying an additional 1,087,446 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in shares of Equifax by 119.3% during the 1st quarter. JPMorgan Chase & Co. now owns 1,453,618 shares of the credit services provider’s stock worth $354,044,000 after buying an additional 790,919 shares during the last quarter. 96.20% of the stock is currently owned by institutional investors and hedge funds.

Equifax Price Performance

Shares of NYSE EFX opened at $234.05 on Friday. Equifax, Inc. has a 1-year low of $199.98 and a 1-year high of $281.07. The business has a 50-day moving average of $244.80 and a 200-day moving average of $251.28. The company has a debt-to-equity ratio of 0.82, a current ratio of 0.74 and a quick ratio of 0.77. The company has a market capitalization of $28.64 billion, a price-to-earnings ratio of 44.41, a PEG ratio of 2.68 and a beta of 1.68.

Equifax (NYSE:EFX) last issued its earnings results on Tuesday, October 21st. The credit services provider reported $2.04 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.10. Equifax had a return on equity of 19.28% and a net margin of 11.08%.The company had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.52 billion. During the same quarter in the prior year, the business earned $1.85 earnings per share. The company’s revenue was up 7.2% compared to the same quarter last year. Equifax has set its Q4 2025 guidance at 1.980-2.080 EPS. FY 2025 guidance at 7.550-7.650 EPS. On average, equities analysts anticipate that Equifax, Inc. will post 7.58 EPS for the current fiscal year.

Equifax Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Tuesday, September 2nd were paid a dividend of $0.50 per share. The ex-dividend date was Tuesday, September 2nd. This represents a $2.00 annualized dividend and a dividend yield of 0.9%. Equifax’s dividend payout ratio (DPR) is currently 37.95%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on EFX shares. BMO Capital Markets dropped their price objective on Equifax from $251.00 to $245.00 and set a “market perform” rating for the company in a report on Wednesday. Bank of America dropped their price objective on Equifax from $285.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, October 3rd. Morgan Stanley restated an “overweight” rating on shares of Equifax in a report on Friday, October 3rd. UBS Group upped their price objective on Equifax from $287.00 to $297.00 and gave the stock a “buy” rating in a report on Monday, September 15th. Finally, Needham & Company LLC restated a “buy” rating and set a $295.00 price objective on shares of Equifax in a report on Tuesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Equifax has an average rating of “Moderate Buy” and a consensus price target of $277.13.

Insider Buying and Selling at Equifax

In other news, CEO Mark W. Begor sold 48,264 shares of the firm’s stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $241.71, for a total transaction of $11,665,891.44. Following the completion of the sale, the chief executive officer directly owned 142,872 shares in the company, valued at $34,533,591.12. This trade represents a 25.25% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.40% of the stock is owned by corporate insiders.

About Equifax

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.